LANCE HOWARD L

SEC source: 0001049521-26-000030 · form4.xml · nonDerivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Howard L. Lance Revocable Living Trust Dated 9/1/2006

Disclosed balance after: 0

F2 · price: This transaction was executed in multiple trades at prices ranging from $98.1000 to $98.9000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001049521-26-000030 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Howard L. Lance Revocable Living Trust Dated 9/1/2006

Disclosed balance after: 1,250

F1 · price: This transaction was executed in multiple trades at prices ranging from $99.3600 to $100.4501. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001049521-26-000013 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,272

F1 · price: This transaction was executed in multiple trades at prices ranging from $88.98 to $89.30. The price reported above reflects the weighted average price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001049521-25-000047 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,104

F1 · shares: Represents restricted stock units that vest on the earlier of the first anniversary of the grant date and the next annual meeting of shareholders.

SEC source: 0000950103-25-001816 · dp224672_4-lance.xml · derivative · entry 4

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 81,611 shares

Expires not disclosed

F1 · price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.exercise_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.expiration_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

SEC source: 0000950103-25-001816 · dp224672_4-lance.xml · derivative · entry 3

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 2,547 shares

Expires not disclosed

F1 · derivative.exercise_price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.exercise_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.expiration_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

SEC source: 0000950103-25-001816 · dp224672_4-lance.xml · derivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 3,341 shares

Expires not disclosed

F1 · derivative.exercise_price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.exercise_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · derivative.expiration_date: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

SEC source: 0000950103-25-001816 · dp224672_4-lance.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

F1 · price: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.

SEC source: 0001628280-25-001881 · wk-form4_1737152877.xml · derivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,547

Underlying: Class A Common Stock · 2,547 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F2 · derivative.exercise_date: These restricted stock units vest on January 15, 2026.

F2 · derivative.expiration_date: These restricted stock units vest on January 15, 2026.

SEC source: 0001127602-24-025989 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,742

F1 · shares: Represents restricted stock units that vest on the earlier of the first anniversary of the grant date and the next annual meeting of shareholders.

SEC source: 0001628280-24-010125 · wk-form4_1709947465.xml · derivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,341

Underlying: Class A Common Stock · 3,341 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2025.

F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2025.

SEC source: 0001628280-24-008675 · wk-form4_1709594425.xml · derivative · entry 3

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 4,038 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F4 · derivative.exercise_date: These restricted stock units vested on February 29, 2024.

F4 · derivative.expiration_date: These restricted stock units vested on February 29, 2024.

SEC source: 0001628280-24-008675 · wk-form4_1709594425.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,363

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis.

F2 · balance_after: Total holdings include shares of Class A Common Stock received pursuant to a stock dividend paid on December 29, 2022.

SEC source: 0001127602-24-004623 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,910

F1 · price: This transaction was executed in multiple trades at prices ranging from $26.67 to $26.7964. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-026338 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,425

F1 · shares: These shares of restricted stock vest on the earlier of the first anniversary of the grant date or the next annual meeting of shareholders.

SEC source: 0001628280-23-033532 · wk-form4_1696291397.xml · derivative · entry 3

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 45,772 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · derivative.exercise_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · derivative.expiration_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

SEC source: 0001628280-23-033532 · wk-form4_1696291397.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Howard L. Lance TTEE Howard Lance Trust dated 09/01/2006

Disclosed balance after: 45,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

SEC source: 0001127602-23-023104 · form4.xml · nonDerivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Howard L. Lance Revocable Living Trust Dated 9/1/2006

Disclosed balance after: 9,250

F1 · price: This transaction was executed in multiple trades at prices ranging from $37.74 to $38.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001628280-23-005886 · wf-form4_167770991526810.xml · derivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 3,815 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F4 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted 3,815 restricted stock units that vested on February 28, 2023.

F4 · derivative.expiration_date: On March 1, 2022, the Reporting Person was granted 3,815 restricted stock units that vested on February 28, 2023.

SEC source: 0001628280-23-005886 · wf-form4_167770991526810.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis.

F2 · balance_after: Total holdings include shares of Class A Common Stock received pursuant to a stock dividend paid on December 29, 2022.

SEC source: 0001628280-23-005103 · wf-form4_167728037238584.xml · derivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,038

Underlying: Class A Common Stock · 4,038 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2024.

F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2024.

SEC source: 0001562180-22-007355 · primarydocument.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,743

F1 · shares: These shares of restricted stock vest at 100% on the first anniversary of the grant date.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 9

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 149,685 shares

Expires 2023-05-22

F6 · price: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

F6 · derivative.exercise_date: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 8

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,439 shares

Expires 2022-11-28

F6 · price: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

F6 · derivative.exercise_date: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 7

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,758 shares

Expires 2023-05-22

F6 · price: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

F6 · derivative.exercise_date: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 6

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,828 shares

Expires 2022-11-28

F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 5

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,320 shares

Expires 2028-05-25

F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0000899243-22-032995 · doc4.xml · derivative · entry 4

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,448 shares

Expires 2027-10-17

F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0000899243-22-032995 · doc4.xml · nonDerivative · entry 3

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · shares: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units.

F3 · price: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units.

SEC source: 0000899243-22-032995 · doc4.xml · nonDerivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,658

F2 · shares: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.

F2 · price: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.

SEC source: 0000899243-22-032995 · doc4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,794

F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.

SEC source: 0001562180-22-005934 · primarydocument.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,767

SEC source: 0001562180-22-005359 · primarydocument.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,767

F1 · shares: These shares of restricted stock vest in two equal installments beginning on June 23, 2023.

SEC source: 0001062993-22-010881 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,514

F1 · shares: Represents the grant of restricted stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer.

SEC source: 0001628280-22-004930 · wf-form4_164634272333600.xml · derivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,815

Underlying: Class A Common Stock · 3,815 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2023.

F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2023.

SEC source: 0001628280-22-004576 · wf-form4_164617470776082.xml · derivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 4,374 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee.

F3 · derivative.exercise_date: On March 30, 2021, the Reporting Person was granted 4,374 restricted stock units that vested on February 28, 2022.

F3 · derivative.expiration_date: On March 30, 2021, the Reporting Person was granted 4,374 restricted stock units that vested on February 28, 2022.

SEC source: 0001628280-22-004576 · wf-form4_164617470776082.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis.

SEC source: 0001062993-21-005923 · form4.xml · derivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,200

Underlying: Common Stock · 63,200 shares

Expires 2023-05-22

F2 · shares: Reflects the vesting of shares of 2.5x stock appreciation rights that were granted in connection with the Company's JV with McKesson as replacement awards for unvested exit-vesting Legacy CHC stock options. The shares of exit-vesting stock appreciation rights vested upon achievement of certain performance criteria on June 22, 2021.

F3 · derivative.exercise_date: These stock appreciation rights are fully vested.

SEC source: 0001062993-21-005923 · form4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,856

F1 · shares: Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 6

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,994

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.02 to $34.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines.

SEC source: 0001104659-21-082174 · a4.xml · derivative · entry 9

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,611

Underlying: Class A Common Stock · 82,500 shares

Expires 2025-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 5

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,994

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.36 to $34.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 4

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-21-082174 · a4.xml · derivative · entry 8

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,111

Underlying: Class A Common Stock · 82,500 shares

Expires 2025-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F5 · derivative.exercise_date: These options are fully vested.

SEC source: 0001104659-21-082174 · a4.xml · derivative · entry 7

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,772

Underlying: Class A Common Stock · 90,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · derivative.exercise_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

F1 · derivative.expiration_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 3

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,994

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.03 to $34.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-21-082174 · a4.xml · nonDerivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock on a one-for-one basis.

SEC source: 0001104659-21-045792 · tm2111872-7_4seq1.xml · derivative · entry 1

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,374

Underlying: Class A Common Stock · 4,374 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee.

F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2022.

F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2022.

SEC source: 0001104659-21-039884 · tm2110456d2_4seq1.xml · nonDerivative · entry 2

LANCE HOWARD L · CIK 0001220679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,994